Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2025 Jun;44(5):1031-1035.
doi: 10.1002/nau.70053. Epub 2025 Apr 10.

Revision Rates for Rechargeable Versus Non-Rechargeable Sacral Neuromodulation Devices in the Management of Overactive Bladder

Tal Cohen  1 , Zhenyue Huang  2 , Arshia Aalami-Harandi  2 , Jiyeon Park  2 , Kaitlyn Sbrollini  2 , Natalie Braun  2 , Steven Weissbart  2 , Justina Tam  2 , Jason Kim  2
Affiliations
Comparative Study

Revision Rates for Rechargeable Versus Non-Rechargeable Sacral Neuromodulation Devices in the Management of Overactive Bladder

Tal Cohen et al. Neurourol Urodyn. 2025 Jun.

Abstract

Purpose: Overactive bladder (OAB) is a prevalent condition that can have a significant impact on quality of life. Sacral neuromodulation (SNM) is proven as an effective treatment option for OAB patients. Rechargeable devices have gained popularity in recent years. However, there is a paucity of data investigating revision rates for rechargeable SNM devices and associated impacting factors.

Materials and methods: We conducted a retrospective cohort study to investigate the revision rates of SNM devices in patients diagnosed with OAB. Patients who underwent implantation of rechargeable or non-rechargeable SNM devices at our institution between January 2019 and June 2023 were included. Revision events, reasons for revisions, and patient demographics were analyzed and compared between the device groups.

Results: The study included 246 patients. One hundred fifty received rechargeable SNM devices and 96 received non-rechargeable devices. Revision rates were significantly different between the two groups, with 34% of patients in the rechargeable device group requiring revisions compared to 13.5% in the non-rechargeable group (p < 0.001). The most common reasons for revision in the rechargeable group included difficulty charging (35.3%) and reduction of symptom improvement (23.5%). Having a rechargeable device resulted in a significantly higher probability of requiring a revision over time compared to non-rechargeable (p < 0.001).

Conclusion: Our study demonstrated that patients who received rechargeable SNM devices were more likely to require revision. Factors such as device malfunction or difficulties connecting to the device may contribute to the higher revision rates. Further studies are needed to elucidate factors affecting revision rates in SNM devices.

Keywords: overactive bladder; sacral neuromodulation; urinary urgency.

PubMed Disclaimer

References

    1. D. E. Irwin, I. Milsom, S. Hunskaar, et al., “Population‐Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study,” European Urology 50, no. 6 (2006): 1306–1314, https://doi.org/10.1016/j.eururo.2006.09.019.
    1. W. Stewart, J. Van Rooyen, G. Cundiff, et al., “Prevalence and Burden of Overactive Bladder in the United States,” World Journal of Urology 20, no. 6 (2003): 327–336, https://doi.org/10.1007/s00345-002-0301-4.
    1. I. Milsom, P. Abrams, L. Cardozo, R. G. Roberts, J. Thüroff, and A. J. Wein, “How Widespread Are the Symptoms of an Overactive Bladder and How Are They Managed? A Population‐Based Prevalence Study,” BJU International 87, no. 9 (2001): 760–766, https://doi.org/10.1046/j.1464-410x.2001.02228.x.
    1. C. L. Amundsen, Y. M. Komesu, C. Chermansky, et al., “Two‐Year Outcomes of Sacral Neuromodulation Versus Onabotulinumtoxin A for Refractory Urgency Urinary Incontinence: A Randomized Trial,” European Urology 74, no. 1 (2018): 66–73, https://doi.org/10.1016/j.eururo.2018.02.011.
    1. C. L. Amundsen, H. E. Richter, S. A. Menefee, et al., “OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial,” Journal of the American Medical Association 316, no. 13 (2016): 1366–1374, https://doi.org/10.1001/jama.2016.14617.

Publication types

LinkOut - more resources